Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Strides Pharma Science Ltd.
NSE: STAR
|
BSE: 532531
|
ISIN: INE939A01011
|
Industry: Pharmaceuticals
|
Strong Performer
1146.9000
-4.50
(
-0.39
%)
NSE
Sep 29, 2026
10:32 AM
49.21% Gain from 52W Low
Volume:
82,696
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Strides Pharma Science Ltd.
27 Aug 2024
1146.90
-0.39%
STRIDES PHARMA SCIENCE LIMITED
Sell:
Strides Pharma Science Ltd.
by
Geojit BNP Paribas
Target: 1175
Recommendation
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 248 to 262 in Jun 2026 qtr.
More from Strides Pharma Science Ltd.
Recommended
Market trades lower, IRFC secures a Rs 4,200 crore loan from DVC
Trendlyne Marketwatch |
29 Sep 2026, 10:29AM
IPO market stays crowded as Snapdeal parent AceVector joins the new-issue rush
|
28 Sep 2026, 06:49PM
Earnings Call Transcript - Q1FY21 for Strides Pharma Science
|
05 Aug 2020